sanjana mukherjee
Georgetown University
Washington, United States
1,981
Total downloads
10k
Total views and downloads
This Research Topic is closed for submissions.
The field of infectious diseases is facing increasing challenges due to the emergence of complex infections that resist conventional therapeutic approaches. Multidrug-resistant organisms, novel viral pathogens, and the intricate interplay of co-infections have pushed the boundaries of existing clinical management strategies. Recent landmark studies highlight an urgent need for more effective interventions, as standard treatments often fail to address the rising morbidity and mortality associated with these complex cases. Current debates focus on optimizing patient outcomes while minimizing the development of resistance, and there is a growing consensus that innovative, multi-pronged approaches are required.
Latest research underscores the importance of integrating cutting-edge diagnostics, precision medicine, and novel therapeutics—including antimicrobial peptides, immunotherapies, and tailored combination regimens—into standard care. Notably, the application of artificial intelligence and digital tools in clinical decision-making has begun to show promise in early detection and personalized treatment plans. However, these advancements are still in their infancy, with limited translational success and insufficient evaluation in real-world settings. Critical gaps persist in understanding pathogen-host interactions, optimizing the use of emerging drugs, and ensuring global access to innovative care models.
This Research Topic aims to consolidate current knowledge and stimulate advancements in the clinical management and therapeutic strategies for complex infectious diseases. Central goals include identifying successful innovations, comparing emerging techniques and their outcomes, and exploring translational pathways from research to practice. By fostering dialogue on effective interventions and implementation barriers, we seek to bridge the gap between laboratory breakthroughs and bedside care.
To gather further insights in the evolving landscape of infectious disease management, we welcome articles addressing, but not limited to, the following themes:
• Novel antimicrobial and antiviral therapies
• Innovations in diagnostic and prognostic tools
• Precision medicine approaches to infectious disease including monoclonal antibodies
• Management of multidrug-resistant and co-infectious cases
• Digital health and artificial intelligence in clinical practice
• Barriers to the implementation of innovative care strategies
• Translational research and real-world evidence in complex infections
• Mechanistic studies of disease pathogenesis and host–pathogen interactions underpinning severe, persistent, or treatment-refractory infections
We encourage the submission of original research articles, systematic reviews, meta-analyses, case reports, and perspectives relevant to these domains.
Keywords: complex infectious diseases, clinical management, therapeutic strategies, multidrug-resistant organisms, antimicrobial resistance, novel antivirals, antimicrobial stewardship, combination therapy, immunotherapy, precision medicine, personalized treatment
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Share on WeChat
Scan with WeChat to share this article
